Hartford, CTNCT06982066Now EnrollingIRB Ready

Pediatric Cancer Clinical Trial in Hartford, CT

Access cutting-edge pediatric cancer treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.

Sponsored by Connecticut Children's Medical Center

Quick Self-Assessment

See if you qualify for this Hartford location

Preparing your pre-screening questions…

Expert Care in Hartford

Access pediatric cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pediatric cancer treatment provided free

Apply for This Hartford Location

Check if you qualify for this pediatric cancer clinical trial in Hartford, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hartford

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hartford site if eligible
  4. 4Begin participation

About This Pediatric Cancer Study in Hartford

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.

Sponsor: Connecticut Children's Medical Center

Who Can Participate

Inclusion Criteria

Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Be aged 15-25 years old at time of enrollment.
Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
Radiotherapy: any radiotherapy to treat the cancer diagnosis.
Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
Be able to speak and read English
Have permission to participate from a member of the patient's primary oncology team.
Provision to sign and date the consent/assent form.
Active study participation of primary oncology clinician
Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute

Exclusion Criteria

An individual who meets and of the following criteria will be excluded from participation in this study:
Not currently on cancer-directed therapy.
Unable to speak and read English.
Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology Clinicians 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hartford?

Yes, this clinical trial (NCT06982066) has an active research site in Hartford, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pediatric Cancer Treatment Options in Hartford, CT

If you're searching for pediatric cancer treatment options in Hartford, CT, this clinical trial (NCT06982066) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pediatric cancer clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Hartford, CT

See all pulmonary embolism clinical trials recruiting in Hartford — not just this study.

Browse Pulmonary Embolism Trials in Hartford →

Browse More Trials by Condition

Pulmonary Embolism TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsPediatric Cancer TrialsAll Conditions →

Ready to Join in Hartford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hartford, CT